Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Pulmozyme to Treat Severe Asthma Episodes

This study has been completed.
Genentech, Inc.
Information provided by (Responsible Party):
Robert A Silverman, North Shore Long Island Jewish Health System Identifier:
First received: September 12, 2005
Last updated: October 9, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2006
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):